Phase 2: Add GHK-Cu (Weeks 2 through 4) Once semaglutide is tolerated at the starting dose (usually by week two or three), introduce GHK-Cu
Patients typically lose 10 to 15 percent of body weight on semaglutide at the higher doses, with strong improvements in A1C, blood pressure, and cardiovascular risk markers
Sipping small amounts frequently, choosing room temperature or slightly cool water, and adding electrolytes can help maintain hydration even when nausea is present
The results found that the treatment effectively increased the concentration of insulin-like growth factor-1
Patients report that even after pancreatitis pain subsides, they experience persistent nausea, early satiety, bloating, and inability to tolerate normal meals classic signs of gastroparesis
A systematic review of data from 265 studies has indicated that no significant association exists between any form of insulin therapy and an increased cancer risk